As of 2025, more than a third of documents were still arriving at American medical facilities the same way they did in 1985: via fax. It's the kind of statistic that prompts groans at health tech conferences, the industry's running joke that also happens to be its most stubborn operational reality.
Basata, a Tempe-based startup, is betting it can turn that anachronism into a business. The company recently closed a $21 million Series A to automate the mountain of paperwork—faxes, lab orders, referrals—that clogs healthcare's administrative arteries. It's an unglamorous problem, perhaps. But also one that sits within a $43 billion administrative burden.
When Venture Capital Meets the Copy Room
Basis Set Ventures led the round, with partner Lan Xuezhao joining Basata's board. The financing drew a collection of familiar Silicon Valley names: Aileen Lee's Cowboy Ventures, Victoria Treyger at Sofeon, and a cohort of healthcare operators who've evidently seen enough fax-induced chaos firsthand. The raise brings Basata's total capital to $24.5 million since the company emerged from stealth with an initial round in mid-2024.
The timing isn't accidental. U.S. hospitals collectively spent $43 billion in 2025 wrestling with denials and prior authorizations, according to the American Hospital Association's "Costs of Caring" report. A separate 2025 survey by Documo—admittedly, a company with its own dog in this fight—found 88% of practitioners saying fax-related delays actively harm patient care.
Whether those figures fully capture the scope of the mess is debatable, but the broader point holds: healthcare administration remains astonishingly manual, and that creates openings for software.
AI Agents in the Waiting Room

Basata's platform uses artificial intelligence to ingest unstructured documents and route them into electronic health record systems without human intervention. The company also deploys voice agents—essentially automated phone attendants with better conversational chops—to handle appointment scheduling and prescription refills around the clock.
The business model diverges from the standard SaaS playbook. Instead of charging per employee seat, Basata bills per document processed and per call handled, a structure the founders say better aligns with the unpredictable surges that define medical office workflows. A flu season spike or a sudden referral backlog translates directly to usage fees rather than forcing practices to license software for phantom users.
Early traction has centered on cardiology. The company says it's processed documents for roughly 500,000 patients to date, with 100,000 of those in the last month alone—a pace that suggests either rapid adoption or heavy concentration among a few large customers. Contracted revenue grew 37-fold over the course of 2025, according to company figures.
Basata has inked partnerships with Tri-City Cardiology in Phoenix and Midwest Cardiovascular Institute in the Chicago area, both announced late last year. A separate deal with MedAxiom—an operational arm of the American College of Cardiology—aims to distribute the AI agents more broadly across cardiology practices nationwide.
The Team Behind the Automaton

CEO Kaled Alhanafi brings a resume rooted in mobility tech: stints at Lyft and Cruise, where he worked on autonomous vehicle deployment. President Chetan Patel spent a decade at Medtronic developing cardiac devices, giving the company credibility inside the notoriously insular world of cardiovascular medicine. CTO Vivin Paliath recently completed a PhD in computer science and is responsible for the underlying AI architecture.
It's a small team—roughly 15 people at last count—but the company is hiring for roles in Tempe and San Francisco, spanning implementation engineering, product management, and what it calls "forward deployment," a term borrowed from Palantir's playbook for embedding engineers directly with clients.
A Suddenly Crowded Field

Basata isn't alone in hunting this market. Tennr, which automates referral workflows, raised $101 million at a $605 million valuation in mid-2025. Assort Health secured $76 million a few months later to build voice AI for specialty practices. The capital flooding into healthcare's back office suggests venture investors see administrative automation as a genuine category, not just a novelty act.
There's also the faint whiff of inevitability to all this. Healthcare has resisted digitization longer and more stubbornly than nearly any other sector, but the economics are starting to bend. Labor shortages, burnout among medical staff, and relentless pressure on reimbursement rates have created conditions where even incremental efficiency gains carry real weight.
Whether Basata can carve out defensible turf in what's likely to become a scrappy, competitive market remains an open question. The fax machine, after all, has survived this long for a reason: it works just well enough, and changing workflows in healthcare is never simple. But the company is banking on the idea that "good enough" has finally stopped being good enough.
